Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Locally advanced prostate cancer: a population-based study of treatment patterns.

Lowrance WT, Elkin EB, Yee DS, Feifer A, Ehdaie B, Jacks LM, Atoria CL, Zelefsky MJ, Scher HI, Scardino PT, Eastham JA.

BJU Int. 2012 May;109(9):1309-14. doi: 10.1111/j.1464-410X.2011.10760.x.

2.

Costs of medical care after open or minimally invasive prostate cancer surgery: a population-based analysis.

Lowrance WT, Eastham JA, Yee DS, Laudone VP, Denton B, Scardino PT, Elkin EB.

Cancer. 2012 Jun 15;118(12):3079-86. doi: 10.1002/cncr.26609.

3.

Ethnic differences in bladder cancer survival.

Yee DS, Ishill NM, Lowrance WT, Herr HW, Elkin EB.

Urology. 2011 Sep;78(3):544-9. doi: 10.1016/j.urology.2011.02.042.

4.

Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy.

Feifer AH, Elkin EB, Lowrance WT, Denton B, Jacks L, Yee DS, Coleman JA, Laudone VP, Scardino PT, Eastham JA.

Cancer. 2011 Sep 1;117(17):3933-42. doi: 10.1002/cncr.25981.

5.

Renal oncocytosis: management and clinical outcomes.

Adamy A, Lowrance WT, Yee DS, Chong KT, Bernstein M, Tickoo SK, Coleman JA, Russo P.

J Urol. 2011 Mar;185(3):795-801. doi: 10.1016/j.juro.2010.10.068.

6.

Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.

Adamy A, Yee DS, Matsushita K, Maschino A, Cronin A, Vickers A, Guillonneau B, Scardino PT, Eastham JA.

J Urol. 2011 Feb;185(2):477-82. doi: 10.1016/j.juro.2010.09.095.

7.

Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.

Yee DS, Shariat SF, Lowrance WT, Maschino AC, Savage CJ, Cronin AM, Scardino PT, Eastham JA.

BJU Int. 2011 Aug;108(4):502-7. doi: 10.1111/j.1464-410X.2010.09848.x. Review.

8.

The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.

Yee DS, Tang Y, Li X, Liu Z, Guo Y, Ghaffar S, McQueen P, Atreya D, Xie J, Simoneau AR, Hoang BH, Zi X.

Mol Cancer. 2010 Jun 23;9:162. doi: 10.1186/1476-4598-9-162.

9.

Complications after radical and partial nephrectomy as a function of age.

Lowrance WT, Yee DS, Savage C, Cronin AM, O'Brien MF, Donat SM, Vickers A, Russo P.

J Urol. 2010 May;183(5):1725-30. doi: 10.1016/j.juro.2009.12.101.

10.

Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.

Yee DS, Shariat SF, Lowrance WT, Sterbis JR, Vora KC, Bochner BH, Donat SM, Herr HW, Dalbagni G, Sandhu JS.

J Urol. 2010 May;183(5):1751-6. doi: 10.1016/j.juro.2010.01.014.

11.

Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes.

Lowrance WT, Elkin EB, Jacks LM, Yee DS, Jang TL, Laudone VP, Guillonneau BD, Scardino PT, Eastham JA.

J Urol. 2010 Apr;183(4):1366-72. doi: 10.1016/j.juro.2009.12.021. Erratum in: J Urol. 2010 Aug;184(2):808.

12.

Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience.

Yee DS, Katz DJ, Godoy G, Nogueira L, Chong KT, Kaag M, Coleman JA.

Urology. 2010 May;75(5):1199-204. doi: 10.1016/j.urology.2009.06.103.

PMID:
20163838
13.
14.

Developments in the surgical management of sporadic synchronous bilateral renal tumours.

Lowrance WT, Yee DS, Maschino AC, Cronin AM, Bernstein M, Thompson RH, Russo P.

BJU Int. 2010 Apr;105(8):1093-7. doi: 10.1111/j.1464-410X.2009.08844.x.

15.

Robot-assisted radical prostatectomy: current evaluation of surgical margins in clinically low-, intermediate-, and high-risk prostate cancer.

Yee DS, Narula N, Amin MB, Skarecky DW, Ahlering TE.

J Endourol. 2009 Sep;23(9):1461-5. doi: 10.1089/end.2009.0144.

PMID:
19619065
16.

Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial.

Yee DS, Lowrance WT, Eastham JA, Maschino AC, Cronin AM, Rabbani F.

BJU Int. 2010 Jan;105(2):185-90. doi: 10.1111/j.1464-410X.2009.08698.x.

17.

Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.

Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P.

BJU Int. 2010 Jan;105(1):16-20. doi: 10.1111/j.1464-410X.2009.08706.x.

18.

Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells.

Inokuchi J, Narula N, Yee DS, Skarecky DW, Lau A, Ornstein DK, Tyson DR.

Int J Cancer. 2009 Jan 1;124(1):68-74. doi: 10.1002/ijc.23928.

19.

Prostate weight and early potency in robot-assisted radical prostatectomy.

Ahlering TE, Kaplan AG, Yee DS, Skarecky DW.

Urology. 2008 Dec;72(6):1263-8. doi: 10.1016/j.urology.2008.05.055.

PMID:
18701150
20.

Repair of rectal injury during robotic-assisted laparoscopic prostatectomy.

Yee DS, Ornstein DK.

Urology. 2008 Aug;72(2):428-31. doi: 10.1016/j.urology.2007.12.022.

PMID:
18455762
Items per page

Supplemental Content

Loading ...
Support Center